On immunophenotyping in the T cell, B cell, and NK cell panel, patients with ATA high-risk thyroid cancer demonstrated overall fewer circulating mononuclear cells (CD45+) compared with ATA low/intermediate risk. The gene discussed is PTPRC; the disease is thyroid gland carcinoma.